KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Non-Current Deferred Tax Liability (2022 - 2025)

Halozyme Therapeutics (HALO) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $231.9 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 130.97% to $231.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $231.9 million through Dec 2025, up 130.97% year-over-year, with the annual reading at $231.9 million for FY2025, 130.97% up from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $231.9 million at Halozyme Therapeutics, up from $8.2 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $231.9 million in Q4 2025, with the low at $3.3 million in Q2 2022.
  • Average Non-Current Deferred Tax Liability over 3 years is $56.9 million, with a median of $13.6 million recorded in 2024.
  • Peak annual rise in Non-Current Deferred Tax Liability hit 130.97% in 2025, while the deepest fall reached 31.24% in 2025.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $29.0 million in 2022, then surged by 246.36% to $100.4 million in 2024, then surged by 130.97% to $231.9 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $231.9 million, $8.2 million, and $100.4 million for Q4 2025, Q3 2025, and Q4 2024 respectively.